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The continuous infection–inflammation cycle plays a crucial role in the progression of cystic fibrosis (CF) disease. This noxious loop can be
aggravated by a reduced partial pressure of oxygen in the blood, hypoxemia, present in CF patients. These interconnected factors, hypoxia,
inflammation and infection, by stabilizing the hypoxia-inducible factor-1α (HIF-1α) protein subunit, are able to activate the transcription factor
HIF-1. To date, data investigating the potential role of HIF-1 in CF are scarce. Our results demonstrated that HIF-1α protein expression was
altered in CF-affected compared to CFTR-corrected airway epithelial cells in unsimulated and simulated hypoxic conditions. In contrast, when
CF-affected cells were infected with Pseudomonas aeruginosa, HIF-1α was more stabilized compared to CFTR-corrected cells. As HIF-1 is
linked with an efficient immune response and pulmonary complications in cystic fibrosis, this difference in HIF-1α protein levels could have an
impact in the CF pathology and the persistence of P. aeruginosa infection.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: HIF-1; Cystic fibrosis; Hypoxia; Pseudomonas aeruginosa1. Introduction
The deterioration of pulmonary function resulting from the
infection–inflammation cycle experienced by patients with cystic
fibrosis (CF) can lead to hypoxemia, reduced partial pressure of
oxygen in blood. More severe forms of hypoxemia can engender
clinical complications such as pulmonary hypertension (1).
Furthermore, hypoxia (reduced oxygen availability) exacerbates
the inflammatory responses (2) and as such could contribute to a
decline in pulmonary function in CF patients. Finally, hypoxic
gradients found in thickmucus onCF epithelial surfaces appear to
promote biofilm associated P. aeruginosa infection (3) and
consequently hypoxia could contribute to long-term survival of
P. aeruginosa in CF lungs and to its associated chronic airway
damage.
Molecular and cellular responses to hypoxia are mediated by
the transcription factor hypoxia-inducible factor-1 (HIF-1).
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doi:10.1016/j.jcf.2011.02.005including cell survival, angiogenesis and energy metabolism that
allow the cell, tissue and organism to adapt to cellular stress
caused by oxygen deficiency (4). HIF-1 is composed of two
protein subunits, HIF-1α and HIF-1β (5), but its transcriptional
activity is dependent on the stabilization of HIF-1α. While
HIF-1β subunit is constitutively expressed in the cells, expression
of HIF-1α protein is regulated at a post-translational level by
prolyl hydroxylase domain (PHD) proteins, through the hydrox-
ylation of HIF-1α and subsequent proteasomal degradation (6).
The activity of PHD enzymes is inhibited by low oxygen tension,
permitting HIF-1α protein stabilization during hypoxia. In
addition to hypoxia, other factors modulate PHD activities, and
consequently adjust HIF-1α expression levels, such as iron and
divalent metal ions (7) and reactive species oxygen (ROS) (8). In
addition, in infected tissues, where the microenvironment is
hypoxic, increasing evidence suggests a key role for HIF-1
signalling, leading to optimization of innate immunity, control of
the pro-inflammatory response and bacterial killing (9).
While HIF-1 has been shown to regulate CFTR expression (10),
there is no data available on the effect of knocking out CFTR
on HIF-1α stabilization, or on the role of the HIF-1 pathway ind by Elsevier B.V. All rights reserved.
Fig. 1. HIF-1α protein level is altered in CF-affected airway epithelial cells.
A. Expression of HIF-1α and β-Actin (loading control) proteins in CF-affected
(IB3-1 cells) and CFTR-corrected airway epithelial cells (S9 cells).
A representative western blot of three independent experiments is shown.
B. Quantification of HIF-1αwas carried out using densitometry. Mean normalized
HIF-1α ratio±SD (n=3) of CF-affected cells relative to CFTR-corrected cells is
presented. Unpaired Student's t-test was performed by comparison of CF-affected
cells with CFTR-corrected cells (**, P-value≤0.01).
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in the progression of the disease.
2. Material and methods
All reagents were obtained from Sigma Aldrich, unless stated
otherwise.
2.1. Cell culture
IB3-1 (ATCC CRL-2777) is a bronchial epithelial cell line
derived from a CF patient with CFTR ΔF508/W1282X alleles
(CF-affected cells). S9 cells (ATCC CRL-2778) are IB3-1 cells
corrected for CFTR expression by transfection with wild-type
adeno-associated viral CFTR (AAVCFTR) (CFTR-corrected
cells). Both cell lines were purchased from the American type
Culture Collection (ATCC, LGC Standards, UK). Cells were
cultured on bovine serum albumin–collagen–fibronectin-coated
flasks using LHC-8 medium (Invitrogen, Ireland) supplemented
with 5% foetal bovine serum (FBS), 100 units/ml penicillin,
100 μg/ml streptomycin (Invitrogen, Ireland) under a 5% CO2
humidified atmosphere at 37 °C.
2.2. Hypoxia-mimetic condition and infection procedure
Cells at 80%of confluenceweremaintained inLHC-8medium
without FBS and antibiotics. For hypoxia-mimetic condition,
cells were treated with the iron chelator and PHD inhibitor,
2,2′-dipyridil (DP) at a concentration of 100 μM for 24 h. For the
infection procedure, Pseudomonas aeruginosa PAO1 originally
obtained fromB. Iglewskiwas cultured aerobically for 16–18 h in
LB media at 37 °C under agitation and subcultured in LHC-8
medium for an additional 3 h. S9 and IB3-1 cells were infected at
an initialmultiplicity of infection (MOI) of 50 to 1 cell. Then, cells
were collected after 1.5, 3 and 6 h of infection.MOIwere checked
by plating serial dilutions of PAO1 onto LB plates.
2.3. Western blotting
Ten micrograms of proteins was resolved on 8% SDS–PAGE
and transferred to nitrocellulose membrane. The following
antibodies were used: mouse anti-human HIF-1α (610958, clone
54, BD Transduction Laboratories) and mouse anti-β-Actin
(A5441, clone AC-15, Sigma Aldrich). Detection was performed
using ECL chemiluminescence (Fisher scientific, Pierce). Band
intensities were determined by densitometry using GeneTools
software (SynGene, Cambridge, UK).
2.4. Statistical analysis
Three independent biological replicates were performed for all
experiments described in this manuscript. The band intensity of
HIF-1α was normalized against that of β-Actin. Results were
expressed as the mean HIF-1α ratio±standard deviation (SD)
(n=3) and analysed relative to control ratios, given the arbitrary
value of 1. Statistical analysis was performed using Student'st-test. Differences were considered significant if the P-value was
≤0.05.
3. Results
To investigate whether HIF-1 complex is altered in CF-affected
lung epithelial cells, we compared the HIF-1α protein levels
between CF-affected (IB3-1) and CFTR-corrected (S9) bronchial
epithelial cell lines. Interestingly, CF-affected cells contained
significantly 40% less HIF-1α protein than cells corrected to
express CFTR (mean HIF-1α ratio: 0.63±0.031; P-value≤0.01)
(Fig. 1). As there was no difference in HIF-1α transcript levels
between cell types (data not shown), the decrease in protein levels
may be due to increased HIF-1α degradation by PHD enzymes in
CF-affected cells, possibly as a result of reduced levels of factors
involved in the inhibition of PHD activity. Alternatively, lack or
dysfunction of CFTR protein could influence HIF-1α expression.
Nonetheless, it is possible that this lower level of HIF-1α protein in
CF-affected cells could interfere with the response to hypoxemia
and infection in CF patients. This led us to investigate the HIF-1α
response inCF-affected cells during pathophysiological conditions.
Therefore, cells were exposed to a hypoxia-mimetic agent, 2,2′-
dipyridil (DP) at a concentration of 100 μM for 24 h. DP treatment
resulted in a significant induction of HIF-1α protein levels in both
cell lines, but with a significantly higher level of induction in
CFTR-corrected (mean HIF-1α ratio: 3.45±0.25; P-value≤0.01)
compared to CF-affected cells (mean HIF-1α ratio: 1.83±0.22;
P-value≤0.05) (Fig. 2). This data suggests that the presence of the
Fig. 2. HIF-1α protein expression is induced in response to simulated hypoxemia
in airway epithelial cells. A. Expression of HIF-1α and β-Actin (loading control)
proteins in CF-affected (IB3-1 cells) and CFTR-corrected airway epithelial cells
(S9 cells) in untreated control (−) or treated with 100 μMof 2,2′-dipyridyl (DP) for
24 h (+). A representative western blot of three independent experiments is shown.
B. Quantification of HIF-1αwas carried out using densitometry.Mean normalized
HIF-1α ratio±SD (n=3) of cells treated with DP relative to untreated cells is
presented. Unpaired Student's t-test was performed by comparison of cells treated
with DP with untreated cells and paired Student's t-test was performed by
comparison of CF-affected cells treated with DPwith CFTR-corrected cells treated
with DP (*, P-value≤0.05; **, P-value≤0.01).
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signalling pathway to stabilize HIF-1α via PHD inhibition,
suggesting that the response to hypoxia may be diminished.
However, other signalling pathways that lead to the stabilization of
HIF-1α may also be perturbed in CF-affected cells.
As Pseudomonas aeruginosa is the primary pathogen
associated with CF lung diseases, we investigated HIF-1α protein
levels in response to infection with P. aeruginosa (PAO1 strain).
Following infection with P. aeruginosa at a MOI of 50 to 1 cell,
HIF-1α protein wasmore stabilized in both cell types compared to
non-infected cells (Fig. 3). However, in CF-affected cells, HIF-1α
stabilization was rapidly induced at one and a half hours
post-infection (mean HIF-1α ratio: 2.91±0.93) with a significant
maximum induction at 3 h post-infection (mean HIF-1α ratio:
5.38±0.85; P-value≤0.05) whereas in CFTR-corrected cells,
HIF-1α stabilization was only induced significantly after 6 h
(mean HIF-1α ratio: 2.28±0.29; P-value≤0.05). This data
indicates that while CF-affected cells showed reduced HIF-1α
stabilization in response to hypoxic conditions compared to cells
corrected to express CFTR, these cells responded toP. aeruginosa
infection by a rapid hyper-stabilization of HIF-1α. This suggests
that different pathways for HIF-1α stabilization may be employed
in the response to hypoxia and infection.4. Discussion
Evidence from this study indicates a new role for HIF-1 in
cystic fibrosis pathology, as suggested by the reduction ofHIF-1α
levels in the absence of a functional CFTR protein in airway
epithelial cells. HIF-1 is known to be regulated by a complex
regulatory network, including both positive and negative factors,
which regulate HIF-1α expression through a variety of
mechanisms including transcription, translation, post-translation-
al modification, protein–protein interaction and degradation (11).
As such, multiple factors associated with CF pathology could
contribute to modulation of HIF-1α levels. For instance, CF
patients are known to have reduced NO levels (12) and NO is
known to play a role in the stability of the HIF-1α subunit (13).
On the other hand, known inducers of HIF-1α stabilization, such
as NF-kB and ROS (2,8) have been shown to be increased in CF
cells (14). This fine balance between positive and negative factors
resulted in reduced HIF-1α levels in CF-affected cells. Further-
more, the fact that HIF-1α stabilization was rapidly hyper-
induced in response to P. aeruginosa suggests that infection was
able to overcome the effect of the CFTR mutation on HIF-1α
levels and/or a distinct pathway of stabilization was employed.
These differences in levels of HIF-1α could have consequences
for the health of CF patients as many HIF-1 target genes could be
linked to the CF pathology.
By driving expression of genes involved in host immunity and
inflammation, studies with HIF-1α knockout mice revealed that
activation of HIF-1 after pathogen interaction (Group A
Streptococcus, Yersinia enteroletica orP. aeruginosa) is essential
for a full inflammatory response in the host (15–17). However, as
we know, CF-affected cells have imbalanced inflammatory
responses during infection. Thus, increased HIF-1α stabilization
following P. aeruginosa infection could be associated with
excessive and deleterious inflammation. Furthermore, a key link
to HIF-1 and P. aeruginosa pathogenesis may be its ability to
facilitate the induction of PA-I Lectin (PA-IL) in P. aeruginosa
upon exposure to epithelial cells (18). PA-IL is a potent barrier-
dysregulating protein and has been shown to facilitate exotoxin A
crossing the intestinal epithelial barrier resulting in lethal gut
derived sepsis in mice (19). PA-IL has also been shown to be
cytotoxic to respiratory epithelial cells and may contribute to
epithelial damage during P. aeruginosa respiratory infections.
Moreover, HIF-1 regulates the critical pro-angiogenic factor
VEGF (vascular endothelial growth factor), which plays an
important role in the development of primary lung graft
dysfunction (PGD) (20). Elevated VEGF levels found in serum
of CF patients have been correlated with enhanced HIF-1 binding
to theVEGFpromoter (21), suggesting that thismay be linked to a
higher susceptibility to PGD inCFpatients. Furthermore, aberrant
activation of the HIF-1-VEGF pathway has been linked to the
development of pulmonary hypertension (22). Indeed, pulmonary
hypertension induced by hypoxia was delayed in heterozygous
deficientHif-1α+/−mice (23). However, to date, the role of HIF-1
in pulmonary hypertension in the context of the CF pathology has
not been studied.
Finally, adenosine has been implicated in tissue protection
during hypoxic conditions and HIF-1, by repressing equilibrative
Fig. 3. HIF-1α protein expression is induced in response to Pseudomonas aeruginosa infection in airway epithelial cells. A. Expression of HIF-1α and β-Actin
(loading control) proteins in CF-affected (IB3-1 cells) and CFTR-corrected airway epithelial cells (S9 cells) in uninfected control (ф) or infected with PAO1 at a MOI of 50
for 1 cell for one and a half hours (1.5), three (3) and six (6) hours. A representative western blot of three independent experiments is shown. B. Quantification ofHIF-1αwas
carried out using densitometry. Mean normalizedHIF-1α ratio±SD (n=3) of infected cells relative to uninfected cells is presented. Unpaired Student's t-test was performed
by comparison of infected cells with uninfected cells and paired Student's t-test was performed by comparison of infected CF-affected cells with infected CFTR-corrected
cells (*, P-value≤0.05).
289C. Legendre et al. / Journal of Cystic Fibrosis 10 (2011) 286–290nucleoside transporter 1 (ENT1) expression, increases extra-
cellular adenosine half-life during hypoxia (24). Since
adenosine is an important regulator of airway surface liquid
volume (25) and serves a protective role during hypoxia and
inflammation (24), this nucleoside could play an essential role
in the progression of the disease. Concerning another HIF-1
target gene potentially involved in CF pathology, the anti-
inflammatory protein netrin-1 seems to be a good candidate as
netrin-1 has been shown to reduce pulmonary inflammation
during the initial stages of acute lung injury (26) and HIF-1α-
dependent induction of netrin-1 attenuates hypoxia-elicited
inflammation at mucosal surfaces (27).
In conclusion, the potential role ofHIF-1 in the pathophysiology
ofCF is raised. This study demonstrates that lower levels ofHIF-1α
protein are found in CF-affected versus CFTR-corrected airway
epithelial cells, independent of hypoxemia, but with a hyper-
stabilization of this protein in response of P. aeruginosa infection.
These differences in the levels of HIF-1α protein could impact on
CF pathology as HIF-1 target genes play a pivotal role during
hypoxia, inflammation and infection. Therefore, further work is
warranted to understand the mechanism underlying the role of
HIF-1 in the context of cystic fibrosis pathology.Acknowledgements
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